Aggressive progression to EGFR tyrosine kinase inhibitors in advanced NSCLC patients: concomitant mutations, prognostic indicator and subsequent management

被引:0
作者
Ruishan Wen
Ying Chen
Jinyu Long
Xiulian Huang
Yuxin Guo
Baoquan Lin
Zongyang Yu
机构
[1] Fujian University of Traditional Chinese Medicine,College of Rehabilitation Medicine
[2] People’s Liberation Army of China,Department of Respiratory and Critical Care Medicine, The 900th Hospital of the Joint Logistic Support Force
[3] Fujian Medical University,Fuzong Clinical Medical College
[4] People’s Liberation Army of China,Department of Cardio
来源
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词
Non-small cell lung cancer; EGFR mutation; 19Del; L858R; Aggressive progression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:8307 / 8316
页数:9
相关论文
共 81 条
  • [41] Lian F(undefined)undefined undefined undefined undefined-undefined
  • [42] Wang X(undefined)undefined undefined undefined undefined-undefined
  • [43] Mok TSK(undefined)undefined undefined undefined undefined-undefined
  • [44] Kim SW(undefined)undefined undefined undefined undefined-undefined
  • [45] Wu YL(undefined)undefined undefined undefined undefined-undefined
  • [46] Mok TS(undefined)undefined undefined undefined undefined-undefined
  • [47] Cheng Y(undefined)undefined undefined undefined undefined-undefined
  • [48] Zhou X(undefined)undefined undefined undefined undefined-undefined
  • [49] Paez JG(undefined)undefined undefined undefined undefined-undefined
  • [50] Jänne PA(undefined)undefined undefined undefined undefined-undefined